Vanguard Group’s NantHealth, Inc NH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-64,575
| Closed | -$129K | – | 4642 |
|
|
2023
Q1 | $129K | Buy |
64,575
+851
| +1% | +$2.52K | ﹤0.01% | 4376 |
|
|
2022
Q4 | $233K | Buy |
63,724
+62
| +0.1% | +$264 | ﹤0.01% | 4280 |
|
|
2022
Q3 | $235K | Hold |
63,662
| – | – | ﹤0.01% | 4392 |
|
|
2022
Q2 | $399K | Sell |
63,662
-8,404
| -12% | -$78.4K | ﹤0.01% | 4339 |
|
|
2022
Q1 | $815K | Sell |
72,066
-44,701
| -38% | -$570K | ﹤0.01% | 4272 |
|
|
2021
Q4 | $1.85M | Buy |
116,767
+89
| +0.1% | +$1.88K | ﹤0.01% | 4071 |
|
|
2021
Q3 | $2.82M | Buy |
116,678
+2,001
| +2% | +$60.2K | ﹤0.01% | 3939 |
|
|
2021
Q2 | $3.99M | Sell |
114,677
-110
| -0.1% | -$4.37K | ﹤0.01% | 3706 |
|
|
2021
Q1 | $5.53M | Buy |
114,787
+1,433
| +1% | +$83.1K | ﹤0.01% | 3478 |
|
|
2020
Q4 | $5.49M | Buy |
113,354
+26,659
| +31% | +$1M | ﹤0.01% | 3323 |
|
|
2020
Q3 | $3.04M | Sell |
86,695
-2,384
| -3% | -$134K | ﹤0.01% | 3358 |
|
|
2020
Q2 | $6.12M | Buy |
89,079
+1,858
| +2% | +$74.1K | ﹤0.01% | 3011 |
|
|
2020
Q1 | $2.08M | Buy |
87,221
+12,696
| +17% | +$304K | ﹤0.01% | 3303 |
|
|
2019
Q4 | $1.15M | Buy |
74,525
+15,561
| +26% | +$206K | ﹤0.01% | 3603 |
|
|
2019
Q3 | $646K | Buy |
58,964
+25,973
| +79% | +$231K | ﹤0.01% | 3757 |
|
|
2019
Q2 | $260K | Sell |
32,991
-4,010
| -11% | -$40.8K | ﹤0.01% | 3931 |
|
|
2019
Q1 | $510K | Sell |
37,001
-3,881
| -9% | -$45K | ﹤0.01% | 3765 |
|
|
2018
Q4 | $334K | Sell |
40,882
-2,201
| -5% | -$38.6K | ﹤0.01% | 3807 |
|
|
2018
Q3 | $1.01M | Buy |
43,083
+967
| +2% | +$36.8K | ﹤0.01% | 3718 |
|
|
2018
Q2 | $2.09M | Sell |
42,116
-410
| -1% | -$20.3K | ﹤0.01% | 3486 |
|
|
2018
Q1 | $1.95M | Sell |
42,526
-5,112
| -11% | -$257K | ﹤0.01% | 3469 |
|
|
2017
Q4 | $2.18M | Sell |
47,638
-26,350
| -36% | -$1.4M | ﹤0.01% | 3395 |
|
|
2017
Q3 | $4.57M | Buy |
73,988
+45,752
| +162% | +$2.68M | ﹤0.01% | 3155 |
|
|
2017
Q2 | $1.79M | Buy |
28,236
+4,739
| +20% | +$263K | ﹤0.01% | 3409 |
|
|
2017
Q1 | $1.75M | Buy |
23,497
+22,302
| +1,866% | +$2.48M | ﹤0.01% | 3418 |
|
|
2016
Q4 | $178K | Sell |
1,195
-52
| -4% | -$9.2K | ﹤0.01% | 3909 |
|
|
2016
Q3 | $246K | Buy |
+1,247
| New | +$229K | ﹤0.01% | 3869 |
|
Vanguard Group's NH Position: Q2 2023 in Review
Vanguard Group sold out of NantHealth, Inc (NH) in Q2 2023, closing a stake of 64,575 shares — an estimated $129K sold.
Vanguard Group first reported a position in NH in Q3 2016 and held it in 27 quarters. The position peaked at $6.12M in Q2 2020. 0 funds tracked by Wall St. Rank hold NH as of Q2 2023.
- Vanguard Group reported no remaining NantHealth, Inc position as of Q2 2023 after selling out during the quarter.
- Vanguard Group sold 64,575 NantHealth, Inc shares in Q2 2023, an estimated $129K.
- Vanguard Group first reported a position in NantHealth, Inc in Q3 2016 and held it in 27 quarters.
- Vanguard Group's NantHealth, Inc position peaked at $6.12M in Q2 2020.
- 0 funds tracked by Wall St. Rank held NantHealth, Inc as of Q2 2023.
Based on Vanguard Group's 13F filing for Q2 2023, filed 14 Aug 2023.